Background: Carotid atherosclerosis should not be neglected as a cause for stroke in China, despite its low prevalence. This study was performed to evaluate the association between ultrasonographic markers for different stages of carotid atherosclerosis and metabolic syndrome. Methods: This was a community-based study in Hong Kong. Metabolic syndrome was defined as having three or more of the following conditions or receiving specific treatment for these conditions: Abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol, hypertension, and impaired fasting blood glucose. All subjects underwent carotid duplex ultrasonography. Mean carotid intima media thickness (CIMT) of bilateral common carotid arteries was used as the CIMT value for a single subject. CIMT within the 4 th quartile was regarded as increased CIMT. Carotid plaque was defined as a focal CIMT of > 1.5 mm. A carotid plaque obstructing ‡ 50% of vessel lumen was considered as carotid stenosis. Results: A total of 653 subjects (mean age 55.1 -10.4; 47.2% male) were recruited. Metabolic syndrome was found in 188 (28.8%) subjects (30.8% in males and 27.0% in females). Mean CIMT was 0.74 -0.12 mm. Increased CIMT, carotid plaque, and carotid stenosis were detected in 163 (25.0%), 95 (14.5%), and 6 (1.4%) subjects, respectively. In multivariate linear regression, CIMT significantly increased with increasing numbers of metabolic syndrome components (P < 0.001). In multivariate logistic regression analysis, metabolic syndrome was independently associated with increased CIMT [odds ratio (OR) 1.17; 95% confidence interval (CI) 1.11-2.64; P = 0.014), but not presence of carotid plaque (OR 1.50; 95% CI 0.92-2.46; P = 0.108). Conclusions: Metabolic syndrome may be independently associated with the early stage but not the later and advanced stages of carotid atherosclerosis in community residents in China.
Introduction

T
here are racial differences in predilection of location of cervicocerebral arterial atherosclerosis between Caucasians and Asians. 1 Despite a relatively lower prevalence in Asians than that in Caucasians, carotid atherosclerosis should not be neglected in Asian populations as a cause for ischemic stroke and transient ischemic attack, which has been increasing during the recent years. [2] [3] [4] [5] [6] Carotid intima media thickness (CIMT), carotid plaque, and carotid stenosis determined by noninvasive ultrasonographic assessment are markers for carotid atherosclerosis and reflect different stages and aspects of atherosclerosis of the carotid arteries.
Increased CIMT mainly represents diffuse hypertensive hypertrophic response of smooth muscle cells, which is the early stage of carotid atherosclerosis, whereas the presence of carotid plaque and carotid stenosis reflects later and advanced stages of the atherosclerotic process. [7] [8] [9] Metabolic syndrome, 10 a cluster of metabolic factors that includes abdominal obesity, elevated triglycerides (TG), low high-density lipoprotein cholesterol (HDL-C), hypertension, and impaired fasting blood glucose (FBG), has been found to be a predictor for different stages of carotid atherosclerosis in large studies in Caucasians. [11] [12] [13] [14] According to a cross-sectional study (2000) (2001) performed in 15,540 subjects aged 35-74 years, a large proportion of Chinese adults have metabolic syndrome, with a prevalence of 13.7% [95% confidence interval (CI), 12.9-14.5%]. 15 Metabolic syndrome incidence is still increasing with changes of lifestyles in China.
In the present study, we evaluated the association between metabolic syndrome and ultrasound-detected markers of carotid atherosclerosis in community-dwelling subjects in Hong Kong and tried to explore reasons for the seemingly paradoxical coexistence of the high prevalence of metabolic syndrome and low prevalence of carotid stenosis in China.
Methods
Subjects
The Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) was a community-based prospective cohort study of cardiovascular risk factors in Hong Kong Chinese. 16, 17 The study was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster, and all subjects provided written informed consent prior to participation. Subjects of CRISPS-3 (2005 CRISPS-3 ( -2008 recruited between April, 2007, and September, 2008, were screened. Those who underwent carotid duplex ultrasonography (CD) and had no missing values for metabolic syndrome components as mentioned below were enrolled in the present cross-sectional study. Smoking habits and histories of common vascular risk factors and medications were collected. Those who had ever smoked, no matter whether they quit or not, were regarded as ever-smokers. Fasting blood was analyzed for FBG, TG, HDL-C, low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC).
Metabolic syndrome
Metabolic syndrome was defined according to the US National Cholesterol Education Program (NCEP) criteria. 10 Subjects with three or more of the following conditions were regarded as having metabolic syndrome: (1) Abdominal obesity (waist circumference ‡ 90 cm for Asian men or ‡ 80 cm for Asian women); (2) elevated TG levels ( ‡ 1.7 mmol/L); (3) low HDL-C levels ( < 1.03 mmol/L in men or < 1.29 mmol/L in women); (4) hypertension (blood pressure ‡ 130/85 mmHg or known hypertension); and (5) impaired FBG levels ( ‡ 5.6 mmol/L or known diabetes mellitus). Receiving specific treatment for a criterion was counted as fulfilling the criterion.
CD protocol
CD was performed by an experienced technician using a Terason t3000 Ultrasound System (Terason TM , Burlington, MA) with a 7-MHz high-resolution linear-array transducer. Longitudinal B-mode images showing the greatest distance between the lumen-intima interface and the media-adventitia interface were stored for subsequent offline analysis, which was performed by another technician unaware of the patients' clinical data, using semiautomatic, computerized edge-detection and measurement software MATH (version 3.0, METRIS Co., Argenteuil, France). CIMT was measured within a plaque-free region with a length of at least 10 mm, at the far wall of common carotid artery (CCA) proximal to the bifurcation. 18 Mean CIMT of bilateral CCAs was regarded as the CIMT value for a single subject. A CIMT value within the 4 th quartile ( > 75 th percentile) was considered as increased CIMT.
Carotid plaque was detected in bilateral CCAs, bifurcations, and the extracranial portion of internal carotid arteries (ICA) and was defined as the presence of focal wall thickening at least 50% greater than that of the surrounding vessel wall, or a focal CIMT greater than 1.5 mm protruding into the lumen. 18 A carotid plaque obstructing ‡ 50% of vessel lumen of CCAs, bifurcations, or extracranial ICAs was considered as carotid stenosis.
Statistical analysis
Demographic characteristics, metabolic syndrome and its components, and other vascular risk factors were compared between those with or without increased CIMT, and those with or without carotid plaques, using the Pearson chisquared test, trend test, or independent samples t-test.
Mean CIMT values of subjects with different numbers of metabolic syndrome components were compared using one-way analysis of variance (ANOVA). A linear regression model was built to evaluate the linear relationship between the number of metabolic syndrome components and CIMT values. Logistic regression models were built to calculate adjusted odds ratios (ORs) of the presence of metabolic syndrome and the number of its components for the presence of increased CIMT and carotid plaque, respectively. All statistical analyses were performed in PASW Statistics (version 18.0, IBM SPSS Statistics, Chicago, IL). Two-sided P values of < 0.05 were considered to be statistically significant.
Results
A total of 653 community-dwelling subjects (mean age 55.1 -10.4; 47.2% male) were recruited. An overview of demographic characteristics, metabolic syndrome components, and other vascular risk factors is shown in Table 1 . Overall, metabolic syndrome was found in 188 (28.8%) subjects (30.8% in male and 27.0% in female), with 124 (19.0%), 196 (30.0%), 145 (22.2%), 115 (17.6%), 51 (7.8%), and 22 (3.4%) subjects having zero to five components, respectively. Abdominal obesity, elevated TG, low HDL-C, hypertension, and impaired FBG were found in 285 (43.6%), 140 (21.4%), 266 (40.7%), 312 (47.8%), and 142 (21.7%) subjects, respectively. Mean CIMT was 0.74 -0.12 mm. The 75 th percentile of CIMT values was 0.795 mm, and 163 (25.0%) subjects had increased CIMT. Carotid plaques were detected in 95 (14.5%) subjects (62 males and 33 females), among whom only 6 (1.4%) had carotid stenosis.
Association between metabolic syndrome and CIMT
Mean CIMT values were significantly increased with increasing numbers of metabolic syndrome components (P < 0.001 for one-way ANOVA; Fig. 1 ). Multivariate linear regression model revealed that the number of metabolic syndrome components was independently related to CIMT values (beta = 0.015 per one component increase with constant age, gender, ever-smoker, TC, and LDL-C; P < 0.001).
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In univariate analysis, subjects with increased CIMT were more likely to have metabolic syndrome (43.6% versus 23.9%, P < 0.001), and they also tended to have more metabolic syndrome components (P < 0.001 for trend; Table 1 and Fig. 2 ). In addition, more of those with increased CIMT had abdominal obesity (50.9% versus 41.2%, P = 0.031), elevated TG (28.2% versus 19.2%, P = 0.015), hypertension (70.6% versus 40.2%, P < 0.001), and impaired FBG (38.0% versus 16.3%, P < 0.001). In multivariate logistic regression (Table 2) , the presence of metabolic syndrome was independently related to increased CIMT (OR 1.17; 95% CI 1.11-2.64; P = 0.014), after adjusting for age, male gender, ever-smoker, TC, and LDL-C. Risks of having increased CIMT significantly increased for those with two, three, four, or five metabolic syndrome components, compared with those without a metabolic syndrome component (all P values < 0.05).
Association between metabolic syndrome and presence of carotid plaque
In univariate analysis (Table 1) , subjects with carotid plaques had a significantly higher incidence of metabolic syndrome, compared with those had no carotid plaque (44.2% versus 26.2%, P < 0.001). They also had more metabolic syndrome components (P < 0.001 for trend; Fig. 3 ), and more of them had elevated TG (32.6% versus 19.5%, P = 0.004), hypertension (70.5% versus 43.9%, P < 0.001), and impaired FBG (41.1% versus 18.5%, P < 0.001). However, metabolic syndrome was not independently related to the presence of carotid plaque (OR 1.50; 95% CI 0.92-2.46; P = 0.108) after adjusting for age, male, and ever-smoker. Compared with those without a metabolic syndrome component, only those with five components (OR 7.92; 95% CI 2.30-27.33; P = 0.001) had significantly higher risk of having carotid plaque ( Table 2 ). The incidence of carotid stenosis was too low (1.4%) in this study to analyze its association with metabolic syndrome.
Discussion
In the present study, we found a high prevalence of metabolic syndrome (28.8%) in community residents in Hong Kong SAR, China. CIMT significantly increased with increasing numbers of metabolic syndrome components. Also, the presence of metabolic syndrome and the number of its components were independent predictors for increased CIMT. However, metabolic syndrome was not independently related to presence of carotid plaque.
The prevalence of metabolic syndrome (30.8% in male and 27.0% in female) in our study was comparable to that in the United States in 1999-2002, which was about 33.7% among men and 35.4% among women, based on the NCEP definition, 10 the same that used in this study except for the criterion of abdominal obesity (102 and 88 cm for American males and females, respectively).
19
According to the results, metabolic syndrome was independently associated with increased CIMT, which represents an early stage of carotid atherosclerosis, but no significant correlation existed between metabolic syndrome and the presence of carotid plaque, the later stage of carotid atherosclerosis. This was similar to a Japanese study performed in 1540 symptomatic subjects, with metabolic syndrome independently related to CIMT > 1.10 mm but not plaque occurrence. 20 Our results were not in accordance with the results of a population-based study with a large sample size (6142 subjects) in eastern China, in which metabolic syndrome and 
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number of its components were reported to be associated with increased CIMT and the presence of carotid plaque in univariate analysis. 21 However, those authors did not provide results of multivariate analysis on these associations. It was possible that the results would be different after adjusting for confounding factors.
The incidence of carotid stenosis was too low (1.4%) in this study for the analysis of its association with metabolic syndrome. A previous study performed among acute ischemic stroke or transient ischemic attack patients admitted to the UCLA Medical Center found that metabolic syndrome was independently related to carotid stenosis in Caucasians (OR 1.98; 95% CI 1.13-3.45), but not in subjects with other ethnic origins, after adjusting for covariates.
14 Another study found metabolic syndrome to be more associated with intracranial arterial stenosis than carotid stenosis in a Korean population. 22 Therefore, by combining the results of our study and previous studies on the association between metabolic syndrome and carotid stenosis, we determined that in populations with Asian origins, although metabolic syndrome might affect the early stage of atherogenesis of carotid arteries, later and advanced stages of carotid atherosclerosis (mainly represented as carotid plaque and carotid stenosis) are more probably due to other factors. This may partly explain the seemingly paradoxical coexistence of the high prevalence of metabolic syndrome and low prevalence of carotid stenosis in China.
The strength of our study was that we evaluated the association between metabolic syndrome and different stages of carotid atherosclerosis in community-dwelling subjects in China, which to some extent further explained the racial difference in the distribution of cervicocerebral arterial atherosclerosis between Caucasians and Asians. However, the small number of subjects with carotid stenosis made it impossible for analysis of its association with metabolic syndrome, which was a limitation of our study. Also, the numbers of male and female subjects with carotid plaques were not large enough for multivariate analysis of genderspecific associations between metabolic syndrome and carotid atherosclerosis.
In conclusion, our study indicated that metabolic syndrome might be independently associated with early-stage carotid atherosclerosis but not later and advanced stages of carotid atherosclerosis in community residents in China. Combined with results of previous studies, we also partly explained the seemingly paradoxical coexistence of the high prevalence of metabolic syndrome and low prevalence of carotid stenosis in China.
